Finerenone is a medication being studied for its ability to help reduce protein levels in the urine of children with chronic kidney disease. It is taken orally and is adjusted based on the child’s age and body weight. The goal is to see if it can improve kidney function when used alongside other treatments.

ACEI (Angiotensin-Converting Enzyme Inhibitors) are medications that help relax blood vessels and reduce blood pressure. They are commonly used to treat high blood pressure and heart conditions. In this trial, they are used in combination with finerenone to see if they can further help reduce protein in the urine and improve kidney health.

ARB (Angiotensin II Receptor Blockers) are another type of medication that helps lower blood pressure by blocking the effects of a hormone that causes blood vessels to tighten. Like ACEIs, ARBs are used in this study to see if they can enhance the effects of finerenone in treating children with chronic kidney disease.

Proteinuria – Proteinuria is a condition characterized by the presence of excess protein in the urine. It often indicates that the kidneys are not functioning properly, as they are allowing protein to leak into the urine instead of retaining it in the bloodstream. This condition can be a sign of kidney damage or disease. Over time, proteinuria can lead to further kidney damage if the underlying cause is not addressed. It is often detected through routine urine tests. The progression of proteinuria depends on the underlying cause and the effectiveness of managing that cause.

Chronic Kidney Disease – Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This decline in kidney function can occur over months or years and is often caused by conditions like diabetes and high blood pressure. As the disease progresses, waste products can build up in the body, leading to symptoms such as fatigue, swelling, and changes in urination. CKD is typically classified into stages based on the level of kidney function, with each stage indicating a more severe level of damage. The progression of CKD can lead to complications such as anemia, bone disease, and cardiovascular issues.